Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

322 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pan-Cancer Analysis of the Mediator Complex Transcriptome Identifies CDK19 and CDK8 as Therapeutic Targets in Advanced Prostate Cancer.
Brägelmann J, Klümper N, Offermann A, von Mässenhausen A, Böhm D, Deng M, Queisser A, Sanders C, Syring I, Merseburger AS, Vogel W, Sievers E, Vlasic I, Carlsson J, Andrén O, Brossart P, Duensing S, Svensson MA, Adler D, Kirfel J, Perner S. Brägelmann J, et al. Among authors: perner s. Clin Cancer Res. 2017 Apr 1;23(7):1829-1840. doi: 10.1158/1078-0432.CCR-16-0094. Epub 2016 Sep 27. Clin Cancer Res. 2017. PMID: 27678455
Nine-gene molecular signature is not associated with prostate cancer death in a watchful waiting cohort.
Mucci LA, Pawitan Y, Demichelis F, Fall K, Stark JR, Adami HO, Andersson SO, Andrén O, Eisenstein AS, Holmberg L, Huang W, Kantoff PW, Perner S, Stampfer MJ, Johansson JE, Rubin MA. Mucci LA, et al. Among authors: perner s. Cancer Epidemiol Biomarkers Prev. 2008 Jan;17(1):249-51. doi: 10.1158/1055-9965.EPI-07-0722. Cancer Epidemiol Biomarkers Prev. 2008. PMID: 18199732
Estrogen-dependent signaling in a molecularly distinct subclass of aggressive prostate cancer.
Setlur SR, Mertz KD, Hoshida Y, Demichelis F, Lupien M, Perner S, Sboner A, Pawitan Y, Andrén O, Johnson LA, Tang J, Adami HO, Calza S, Chinnaiyan AM, Rhodes D, Tomlins S, Fall K, Mucci LA, Kantoff PW, Stampfer MJ, Andersson SO, Varenhorst E, Johansson JE, Brown M, Golub TR, Rubin MA. Setlur SR, et al. Among authors: perner s. J Natl Cancer Inst. 2008 Jun 4;100(11):815-25. doi: 10.1093/jnci/djn150. Epub 2008 May 27. J Natl Cancer Inst. 2008. PMID: 18505969 Free PMC article.
The role of SPINK1 in ETS rearrangement-negative prostate cancers.
Tomlins SA, Rhodes DR, Yu J, Varambally S, Mehra R, Perner S, Demichelis F, Helgeson BE, Laxman B, Morris DS, Cao Q, Cao X, Andrén O, Fall K, Johnson L, Wei JT, Shah RB, Al-Ahmadie H, Eastham JA, Eggener SE, Fine SW, Hotakainen K, Stenman UH, Tsodikov A, Gerald WL, Lilja H, Reuter VE, Kantoff PW, Scardino PT, Rubin MA, Bjartell AS, Chinnaiyan AM. Tomlins SA, et al. Among authors: perner s. Cancer Cell. 2008 Jun;13(6):519-28. doi: 10.1016/j.ccr.2008.04.016. Cancer Cell. 2008. PMID: 18538735 Free PMC article.
Testing a multigene signature of prostate cancer death in the Swedish Watchful Waiting Cohort.
Mucci LA, Pawitan Y, Demichelis F, Fall K, Stark JR, Adami HO, Andersson SO, Andrén O, Eisenstein A, Holmberg L, Huang W, Kantoff PW, Kim R, Perner S, Stampfer MJ, Johansson JE, Rubin MA. Mucci LA, et al. Among authors: perner s. Cancer Epidemiol Biomarkers Prev. 2008 Jul;17(7):1682-8. doi: 10.1158/1055-9965.EPI-08-0044. Epub 2008 Jun 26. Cancer Epidemiol Biomarkers Prev. 2008. PMID: 18583469 Free PMC article.
Distinct genomic aberrations associated with ERG rearranged prostate cancer.
Demichelis F, Setlur SR, Beroukhim R, Perner S, Korbel JO, Lafargue CJ, Pflueger D, Pina C, Hofer MD, Sboner A, Svensson MA, Rickman DS, Urban A, Snyder M, Meyerson M, Lee C, Gerstein MB, Kuefer R, Rubin MA. Demichelis F, et al. Among authors: perner s. Genes Chromosomes Cancer. 2009 Apr;48(4):366-80. doi: 10.1002/gcc.20647. Genes Chromosomes Cancer. 2009. PMID: 19156837 Free PMC article.
N-myc downstream regulated gene 1 (NDRG1) is fused to ERG in prostate cancer.
Pflueger D, Rickman DS, Sboner A, Perner S, LaFargue CJ, Svensson MA, Moss BJ, Kitabayashi N, Pan Y, de la Taille A, Kuefer R, Tewari AK, Demichelis F, Chee MS, Gerstein MB, Rubin MA. Pflueger D, et al. Among authors: perner s. Neoplasia. 2009 Aug;11(8):804-11. doi: 10.1593/neo.09572. Neoplasia. 2009. PMID: 19649210 Free PMC article.
ERG rearrangement metastasis patterns in locally advanced prostate cancer.
Perner S, Svensson MA, Hossain RR, Day JR, Groskopf J, Slaughter RC, Jarleborn AR, Hofer MD, Kuefer R, Demichelis F, Rickman DS, Rubin MA. Perner S, et al. Urology. 2010 Apr;75(4):762-7. doi: 10.1016/j.urology.2009.10.010. Urology. 2010. PMID: 20018353 Free PMC article.
Molecular sampling of prostate cancer: a dilemma for predicting disease progression.
Sboner A, Demichelis F, Calza S, Pawitan Y, Setlur SR, Hoshida Y, Perner S, Adami HO, Fall K, Mucci LA, Kantoff PW, Stampfer M, Andersson SO, Varenhorst E, Johansson JE, Gerstein MB, Golub TR, Rubin MA, Andrén O. Sboner A, et al. Among authors: perner s. BMC Med Genomics. 2010 Mar 16;3:8. doi: 10.1186/1755-8794-3-8. BMC Med Genomics. 2010. PMID: 20233430 Free PMC article.
mRNA expression signature of Gleason grade predicts lethal prostate cancer.
Penney KL, Sinnott JA, Fall K, Pawitan Y, Hoshida Y, Kraft P, Stark JR, Fiorentino M, Perner S, Finn S, Calza S, Flavin R, Freedman ML, Setlur S, Sesso HD, Andersson SO, Martin N, Kantoff PW, Johansson JE, Adami HO, Rubin MA, Loda M, Golub TR, Andrén O, Stampfer MJ, Mucci LA. Penney KL, et al. Among authors: perner s. J Clin Oncol. 2011 Jun 10;29(17):2391-6. doi: 10.1200/JCO.2010.32.6421. Epub 2011 May 2. J Clin Oncol. 2011. PMID: 21537050 Free PMC article.
322 results